Startup based in the United States, 2 tracked investors.
Based in the United States, Asher Bio is a startup founded in 2019. Brouky records 2 investors associated with the company.
Asher Bio develops cis-targeted immunotherapies that selectively activate specific immune cell types to improve efficacy and reduce side effects in cancer treatment.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.